On March 5, 2009, GTx, Inc. issued a press release announcing that the United States Food and Drug Administration (FDA) will target a Prescription Drug User Fee Act agency action date of October 30, 2009 for the toremifene 80 mg New Drug Application (NDA), which is within 10 months of the submission of the NDA, a copy of which is furnished as Exhibit 99.1 to this Current Report.

(c) Exhibits

         Exhibit
         Number    Description
         99.1      Press Release issued by GTx, Inc. dated March 5, 2009